BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35845958)

  • 21. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNPY4 is a potential promising prognostic-related biomarker and correlated with immune infiltrates in gliomas.
    Li JW; Huang QR; Mo LG
    Medicine (Baltimore); 2022 Aug; 101(33):e30044. PubMed ID: 35984129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower-grade gliomas.
    Ji Q; Huang K; Jiang Y; Lei K; Tu Z; Luo H; Zhu X
    Cancer Med; 2022 May; 11(9):2020-2035. PubMed ID: 35142109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
    Xu B
    Medicine (Baltimore); 2021 Jan; 100(3):e23513. PubMed ID: 33545929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New biomarker: the gene HLA-DRA associated with low-grade glioma prognosis.
    Chen D; Yao J; Hu B; Kuang L; Xu B; Liu H; Dou C; Wang G; Guo M
    Chin Neurosurg J; 2022 May; 8(1):12. PubMed ID: 35585639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
    Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
    Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aquaporin-4 as a New Potential Molecular Biomarker for Prognosis of Low-Grade Glioma: Comprehensive Analysis Based on Online Platforms.
    Zhu J; Shi L; Su Y
    World Neurosurg; 2023 Jul; 175():e713-e722. PubMed ID: 37037365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma.
    Ma W; Mei P
    World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
    Peng S; Wang G; Cheng Z; Guo Z
    Int J Gen Med; 2021; 14():4381-4393. PubMed ID: 34413671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
    Su X; Li H; Chen S; Qin C
    Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
    Qiu H; Tian W; He Y; Li J; He C; Li Y; Liu N; Li J
    Front Oncol; 2021; 11():654350. PubMed ID: 33954112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
    Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
    J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Hub Genes of Mesio Temporal Lobe Epilepsy and Prognostic Biomarkers of Brain Low-grade Gliomas Based on Bioinformatics Analysis.
    Xu J; Sun M; Wang Y; Xie A; Gao J
    Cell Transplant; 2020; 29():963689720978722. PubMed ID: 33327771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prokineticin 1 induces a pro-inflammatory response in murine fetal membranes but does not induce preterm delivery.
    Lannagan TR; Wilson MR; Denison F; Norman JE; Catalano RD; Jabbour HN
    Reproduction; 2013 Dec; 146(6):581-91. PubMed ID: 24051059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment.
    Wang F; Tao Z; Tian Z; Jin J; Dong J; Dai Y; Yu W; Tang B; Hu S
    Front Genet; 2022; 13():874896. PubMed ID: 35865011
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic value of γ-aminobutyric acidergic synapse-associated signature for lower-grade gliomas.
    Jiang H; Sun Z; Li F; Chen Q
    Front Immunol; 2022; 13():983569. PubMed ID: 36405708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
    Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q
    Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.